Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury
Open Access
- 1 May 2000
- Vol. 46 (5) , 719-724
- https://doi.org/10.1136/gut.46.5.719
Abstract
BACKGROUND Transforming growth factor β (TGF-β) regulates hepatocyte proliferation and biosynthesis of the extracellular matrix. AIMS This study investigated alternations in sensitivity to TGF-β1 and binding properties for ligand in hepatocytes and hepatic stellate cells (HSC) after CCl4 administration. METHODS Plasma TGF-β1 levels in rats after CCl4 administration were determined using ELISA. Effects of TGF-β1 were examined by DNA synthesis in hepatocytes and by measurement of fibronectin production in HSC after CCl4 administration. Binding of125I TGF-β1 was tested in these cells. RESULTS Plasma TGF-β1 levels were increased as early as 24 hours and were maximal by 48 hours . The antiproliferative response to TGF-β1 decreased in hepatocytes at 48 hours and normalised at 72 hours. Fibronectin production of both normal and injured HSC was affected by TGF-β1 treatment. Cross linked ligand/receptor complexes were detected in normal hepatocytes and HSC. However, these levels decreased specifically in hepatocytes at 48 hours and normalised by 72 hours. CONCLUSIONS Downregulation of TGF-β receptor occurred in hepatocytes after chemical insult and TGF-β1 could not transduce its antiproliferative signal. Recovery of TGF-β receptor expression causes the signal to transduce to the nucleus at 72 hours. In HSC, whenever TGF-β1 is increased, TGF-β1 can transduce its signal for fibronectin production via its receptor because signalling receptors are expressed constantly.Keywords
This publication has 26 references indexed in Scilit:
- Fat-storing cells of the rat liver: Their isolation and purificationPublished by Elsevier ,2004
- Differential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administrationJournal of Hepatology, 1998
- The hepatic stellate (Ito) cell: its role in human liver diseaseVirchows Archiv, 1997
- Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor GeneJournal of Biological Chemistry, 1995
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.Proceedings of the National Academy of Sciences, 1988
- Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary cultureBiochemical and Biophysical Research Communications, 1985